Tag/Conjugate
Unconjugated
Antigen Description
This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. This gene was identified by its ability to proteolytically cleave and activate the inactive precursor of interleukin-1, a cytokine involved in the processes such as inflammation, septic shock, and wound healing. This gene has been shown to induce cell apoptosis and may function in various developmental stages. Studies of a similar gene in mouse suggest a role in the pathogenesis of Huntington disease. Alternative splicing results in transcript variants encoding distinct isoforms. [provided by RefSeq, Mar 2012]
Function
cysteine-type endopeptidase activator activity involved in apoptotic process; cysteine-type endopeptidase activity; cysteine-type endopeptidase activity; endopeptidase activity; protein binding
Synonyms
CASP1; caspase 1, apoptosis-related cysteine peptidase; ICE; P45; IL1BC; caspase-1; IL1B-convertase; CASP1 nirs variant 1; IL-1 beta-converting enzyme; interleukin 1, beta, convertase; interleukin 1-B converting enzyme; caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)
Citations
Have you cited CDBP5251 in a publication?
Let us know and earn a reward for your research.
Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Di Tommaso, C; Torriglia, A; et al. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. INTERNATIONAL JOURNAL OF PHARMACEUTICS 416:515-524(2011).
Mueller, A; Bachmann, E; et al. Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines. CANCER CHEMOTHERAPY AND PHARMACOLOGY 69:1601-1615(2012).